Chemomab Therapeutics Ltd.
Cash Flow Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-9.8M | $-4.7M |
| Depreciation & Amortization | — | — |
| Depreciation | — | — |
| Amortization | — | — |
| Stock-Based Compensation | $700.0K | — |
| Net Cash from Operating Activities | $-8.5M | $-3.7M |
| Investing Activities | ||
| Capital Expenditures | $34.0K | $75.0K |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $-34.0K | $78.0K |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $5.2M | $6.1M |
| Net Change in Cash | — | — |
| Free Cash Flow | $-8.5M | $-3.8M |